Treatment of Juvenile Idiopathic Arthritis

излечение ревматоидного артрита

излечение ревматоидного артрита

The following letter was written by the J. family to the iMER company. They contacted us while looking for a solution to the medical challenges faced by their 15 year old daughter who was suffering from J.I.A. – Juvenile Idiopathic Arthritis. JIA is a subset of arthritis seen in childhood, which may be transient and self-limited or chronic. It is an autoimmune disorder.

Treatment was administered in Russia with Sulfasalazin together with Dicofenac followed by Meloxicam – this protocol brought with it terrible complications. The child developed Toxic Epidermal Necrolysis over 70% of her body. She needed resuscitation and was in a life threatening situation.

It was clear to the family that their daughter required immediate and specialized medical attention- Her medical material was reviewed by Dr. Berkune, a Pediatric immunology specialist and they accepted the offer to bring her to the Hadassah Medical Center in Ein Kerem.This is the heartwarming letter they sent us:

“Thank you to the wonderful team at iMER – Luba, Sasha and Leah for the help with the treatment and cure for our daughter. I pray that the treatment and warm concern will come back to you 100 fold.
With great respect and a million thanks,
The J. family 25.08.2011”

For more information click here >>

Patients’ Stories

Natalya, 47 y. o. patient from Moscow, needed a primary examination and guidelines for multiple sclerosis treatment in Israel. Dr. Benshtein helped to organize and coordinate patient’s visit to Hadassah University clinic. Dear Dr. Benshtein, Thank you very much for the starting of my treatment I got at the Hadassah hospital (28.08.2011 – 11.09.2011). Thank you for the planning, orchestrating and coordinating as well as logistic preparation. It was great pleasure to contact iMER and especially iMER personnel who helped very much. During the initial
Read More >>